Did you know?
Fairleigh Dickinson was issued a patent for the BD Luer-Lok™ syringe in 1925.
Learn more about BD's history »
Focus Areas
Parenteral & BioMaterial Technologies
MissionMaximize therapeutic effectiveness of biopharmaceutical products via non- and minimally-invasive drug delivery technologies and maintain or improve the performance of biomolecules via biomaterial technologies OverviewThe Parenteral & BioMaterial Technologies group at BD Technologies is developing novel and proprietary drug delivery and biomaterial technologies designed to enhance the therapeutic value and improve the performance of biomolecules. Over the past 100 years, BD has developed a wealth of knowledge about effective parenteral drug delivery. An example of one platform technology being developed is microneedle delivery for intradermal administration, where BD has extensive expertise with a variety of pharmaceutical agents.
|